NASDAQ:NXGN
Delisted

Nextgen Healthcare Stock News

etoro logo Buy NXGN
*Your capital is at risk
$23.94
+0 (+0%)
At Close: Feb 07, 2024
NextGen's (NXGN) latest product is expected to simplify connectivity for healthcare providers, thereby solving clinical data exchange challenges.
NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.
NextGen's (NXGN) Behavioral Health Suite is expected to aid Compass Health in improving its workflow.
Nextgen Healthcare (NXGN) reported earnings 30 days ago. What's next for the stock?
NextGen's (NXGN) third-quarter fiscal 2023 results reflect strength in its Recurring revenues.
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of -3.70% and 1.08%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NextGen Healthcare, Inc. (NASDAQ:NXGN ) Q3 2023 Earnings Conference Call January 24, 2023 5:00 PM ET Company Participants James Hammerschmidt - Senior Vice President, Finance, and Investor Relations D
Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.
Defensive and resilient healthcare has a strategic and tactical role to play within allocation of equity risk. We've stated numerous times below the benefits of holding a low beta, low gamma allocatio

NextGen (NXGN) Buys TSI Healthcare to Boost Ambulatory Services

01:12pm, Friday, 02'nd Dec 2022 Zacks Investment Research
NextGen (NXGN) acquires TSI Healthcare which may further solidify NXGN's position in the ambulatory healthcare space.
NextGen (NXGN) acquires TSI Healthcare which may further solidify NXGN's position in the ambulatory healthcare space.

NextGen Healthcare (NXGN) Q2 Earnings Beat, FY23 View Up

02:31pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
NextGen's (NXGN) second-quarter fiscal 2023 results reflect strength in both its revenue sources.

Nasdaq Dips 1.5%; Alphabet Misses Q3 Estimates

02:07pm, Wednesday, 26'th Oct 2022 Benzinga
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 1.5% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.10% to 31,868.78 while the NASDAQ
NextGen's (NXGN) second-quarter fiscal 2023 results reflect strength in both its revenue sources.

Nextgen Healthcare (NXGN) Beats Q2 Earnings and Revenue Estimates

10:15pm, Tuesday, 25'th Oct 2022 Zacks Investment Research
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 4.17% and 1.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE